Trials / Completed
CompletedNCT03340870
A Study to Evaluate Pharmacokinetics of Sonazoid™ Following Intravenous Bolus Injection in Healthy Volunteers
Pharmacokinetics of Sonazoid™ Following Intravenous Bolus Injection in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- GE Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to determine the Pharmacokinetics (PK) data of perfluorobutane (PFB) in blood and exhaled air following intravenous (I.V.) bolus injection of Sonazoid™ in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sonazoid™ | Single Dose of Sonazoid™ lipid-stabilised aqueous suspension of perfluorobutane (PFB) gas microbubbles. |
Timeline
- Start date
- 2014-10-20
- Primary completion
- 2014-11-20
- Completion
- 2014-11-20
- First posted
- 2017-11-14
- Last updated
- 2017-11-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03340870. Inclusion in this directory is not an endorsement.